semaglutide compound dose GLP-1 Rx Semaglutide for weight loss |
Description
Liquid presentation in an easy-to-use dropper

holding the medication

Led by graduate student Jordan Miller '25 and Professor David Han, the team studied national poison control center data and identified a sharp rise in semaglutide-related calls following the FDAs 2021 approval of the medication for chronic weight management

Semaglutide (Ozempic)

New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy, a telehealth platform that connects patients with licensed healthcare providers, announced today the expansion of its online program designed to help eligible adults with type 2 diabetes explore Ozempic treatment options through remote medical evaluations, insurance coordination, prescription management, and ongoing provider support

Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials
